Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In VitroHoon Sik Choi, Bae Kwon Jeong|Molecules|2021Cited by 41
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated CytotoxicityHoon Sik Choi, Hye Jung Kim|International Journal of Molecular Sciences|2022Cited by 14
Sarcopenia using pectoralis muscle area and lymphocyte-to-monocyte ratio (LMR) are independent prognostic factors in patients for nonmetastatic breast cancerHaa‐Na Song, Bae Kwon Jeong, Jae Myung Kim et al.|Medicine|2022Cited by 10